National and Kapodistrian University of Athens
Γενετικές και επιγενετικές αλλαγές στο μονοπάτι σηματοδότησης p13k / akt στον καρκίνο της ουροδόχου κύστεως
Abstract
dc:descriptionThe purpose of this PhD thesis was to examine the involvement of specific components of the PI3K/AKT pathway in urinary bladder cancer. Samples from sixty-five tumors and thirteen normal bladder tissues were collected. Genomic DNA isolation from snap-frozen and paraffin-embedded laser-microdissected tissues was followed by Sanger sequencing, whereas total RNA was purified for use in RT-PCR analyses. Immunohistochemistry was carried out on sections of paraffin-embedded biopsy material.Three pathogenic mutations (two missense and one frameshift) were identified in exon 20 of PIK3CA {c.3140A>G (p.His1047Arg), c.[3172A>T(;)3174C>T] (p.lle1058Phe), c.3203dupA (p.Asn1068Lysfs*5)} after laser capture microdissection, whereas PTEN mRNA expression was found to be downregulated in bladder cancer tissues compared to normal bladder urothelium. Upregulation of cytoplasmic and nuclear p-AKT expression was detected in low grade tumors, whereas in muscle invasive tumors, p-AKT was shown to be downregulated and confined to the cytoplasm. PTEN expression was weak and mainly cytoplasmic in superficial tumors, but stronger and nuclear in the muscle invasive tumors.In conclusion, PI3K/AKT pathway activation is involved in bladder cancer initiation and progression. In this context, PIK3CA, p-AKT and nuclear PTEN could be used along with other biomarkers for prognostic purposes and for the selection of appropriate therapy in the clinical management of bladder cancer.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kachrilas, Stefanos
- Καχρίλας, Στέφανος
Subjects
dc:subject × 7Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/43242